PhaseBio Pharmaceuticals, Inc. (PHAS)

Pre-Tax Margin

-8012.02%

Quarterly · Period ending:

PHAS logo

PHAS Pre-Tax Margin

Latest reported-8012.02%
PHAS Quarterly Pre-Tax Margin (0.00% → -8012.02%)
High-resolution chart · PNG

PHAS pre-tax margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Pre-Tax Margin — Quarterly
Period endingPre-Tax Margin
-8,012.0192%
-9,522.2222%
54,576.9171%
-9,529.5522%
-261.9365%
0%
-9,492,187,500,000,000%
-10,432.7801%
-4,003.1294%
-4,657.8125%
-1,483.1152%
-4,726.556%
-1,313.229%
-1,116.8453%
-1,894.1634%
-1,922.3844%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.